KLOW peptide protocol is the research-specific application plan for the blend covering reconstitution, storage, aliquot preparation, and the experimental delivery method for the model system being studied
Neither compound has been approved as a medicine by any regulator - not the TGA in Australia, the FDA in the United States, or the EMA in Europe - for any use
This 20mg total blend (5mg/5mg per vial) is verified to a minimum purity of 99% per component via independent, lot-specific Janoshik Certificates of Analysis
Our approach is often a two-step process
Whether you are receiving B12 shots, lipotropic injections, or both, these three habits form the foundation that allows any clinical intervention to perform at its best: Protein-forward nutrition at every meal